2025 HCPCS Code C9753
Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)
TAGS: guidance separately additional imaging intraosseous basivertebral addition vertebral destruction primary| Notice | HCPCS C9753 terminated on December 31, 2021. |
| Short Description | Intraosseous destruct add'l |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 2019 |
| HCPCS Action Effective Date | January 01, 2022 |
| HCPCS Pricing Indicator Code | 53 - Statute |
| HCPCS Type Of Service Code | 2 - Surgery |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9122 - Mometasone furoate (sinuva)
- C9132 - Kcentra, per i.u.
- C9133 - Factor ix recombinant
- C9134 - Factor xiii a-subunit recomb
- C9135 - Factor ix (alprolix)
- C9136 - Factor viii (eloctate)
- C9137 - Adynovate factor viii recom
- C9138 - Nuwiq factor viii recomb
- C9139 - Idelvion, 1 i.u.
- C9140 - Afstyla factor viii recomb
- C9141 - Factor viii pegylated-aucl
- C9142 - Inj, alymsys, 10 mg
- C9143 - Cocaine hcl nasal (numbrino)
- C9144 - Inj, bupivacaine (posimir)
- C9145 - Inj, aponvie, 1 mg
- C9146 - Inj, elahere, 1 mg
- C9147 - Inj, tremelimumab-actl, 1 mg
- C9148 - Inj, teclistamab-cqyv, 0.5mg
- C9149 - Inj, teplizumab-mzwv, 5 mcg
- C9150 - Xe129 xenon, diagnostic